Impaired glucose homeostasis after a transient intermittent hypoxic exposure in neonatal rats

Eung-Kwon Pae1, Bhoomika Ahuja, Marieyerie Kim

  • 1UCLA, School of Dentistry, LA, CA 90095, United States.

Insights

Neonatal intermittent hypoxia (IH) exposure in rats creates a lasting diabetes-like condition. This study shows IH disrupts glucose homeostasis and lowers insulin levels in young rats without causing inflammation.

Area of Science:

  • Endocrinology
  • Neonatal physiology
  • Metabolic disorders

Background:

  • Intermittent hypoxia (IH) is linked to various health issues.
  • Neonatal exposure to IH may have long-term metabolic consequences.
  • Understanding early-life IH effects is crucial for preventing metabolic diseases.

Purpose of the Study:

  • To establish a neonatal rat model for studying the effects of transient intermittent hypoxia (IH).
  • To investigate the long-term impact of neonatal IH exposure on glucose homeostasis and insulin regulation.
  • To determine if neonatal IH induces diabetes-like conditions in young rats.

Main Methods:

  • Neonatal male rat pups were exposed to transient intermittent hypoxia (IH) for 5 hours on postnatal day 1.
  • IH involved alternating oxygen levels between 10.3% and 20.8%.
  • Treated rats were compared to age-matched controls after 3 weeks in normal oxygen.

Main Results:

  • IH-exposed rats showed significantly higher fasting glucose levels (237.00 ± 19.66 mg/dL vs. 167.25 ± 2.95 mg/dL).
  • Insulin levels were significantly lower in IH-exposed rats (807.0 ± 72.5 pg/mL vs. 1839.8 ± 377.6 pg/mL).
  • Glucose tolerance tests revealed disturbed glucose homeostasis, with decreased C-peptide secretion (914 pM vs. 809 pM).

Conclusions:

  • Neonatal exposure to transient IH can induce a persistent diabetes-like condition in rats.
  • IH exposure disrupts glucose homeostasis and insulin secretion without affecting beta-cell mass or causing inflammation.
  • This model provides insights into early-life IH-induced metabolic dysregulation.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
45
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.4K